Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued a report on the stock […]

Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) and CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Earnings and Valuation This table compares Cullinan […]

Wedbush restated their outperform rating on shares of Cullinan Therapeutics (NASDAQ:CGEM – Free Report) in a report published on Wednesday morning, Benzinga reports. The firm currently has a $36.00 price objective on the stock. CGEM has been the topic of several other research reports. HC Wainwright reissued a buy rating and issued a $28.00 price […]

Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have been given an average rating of “Buy” by the nine research firms that are presently covering the stock, MarketBeat reports. Eight analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […]